On Thursday, Following U.S. Stocks were among the “Top Gainers”: Millennial Media Inc. (NYSE:MM), Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE), Morgan Stanley (NYSE:MS)
Millennial Media, Inc.(NYSE:MM), with shares inclined 6.38%, closed at $1.50.
Ampio Pharmaceuticals Inc (NYSEMKT:AMPE), with shares jumped 6.24%, settled at $6.98.
Morgan Stanley (NYSE:MS), with shares climbed 6.12%, and closed at $37.09.
Latest NEWS regarding these Stocks are depicted underneath:
Millennial Media Inc. (NYSE:MM)
Millennial Media Inc. (MM), the leading independent mobile advertising marketplace, stated financial results for the fourth quarter and full year ended December 31, 2014.
Financial Results and Business Highlights for the Fourth Quarter of 2014:
Proceed: For the fourth quarter of 2014, proceed was $86.4 million contrast to $96.7 million in the fourth quarter of 2013.
Gross Margin: For the fourth quarter of 2014, gross margin was 38.3% contrast with gross margin of 38.7% for the fourth quarter of 2013.
Net Revenue (Loss): For the fourth quarter of 2014, on a GAAP basis, net loss was $(11.6) million, contrast to net loss of $(3.7) million for the fourth quarter of 2013.
Adjusted EBITDA: For the fourth quarter of 2014, Adjusted EBITDA, a non-GAAP financial measure (see definition below), was a loss of $(1.8) million, contrast to Adjusted EBITDA of $7.6 million for the fourth quarter of 2013.
Net Revenue (Loss) per Share: For the fourth quarter of 2014, on a GAAP basis, basic and diluted net loss per share was $(0.10), contrast to basic and diluted net loss per share of $(0.04) for the fourth quarter of 2013.
Non-GAAP Net Revenue (Loss) Per Share: For the fourth quarter of 2014, non-GAAP net loss per share (see definition below) was $(0.02), contrast to non-GAAP net revenue per share of $0.08 for the fourth quarter of 2013.
Other Business Metrics: As of December 31, 2014, Millennial Media reached over 650 million monthly unique users globally, counting about 175 million monthly unique users in the United States alone. As of December 31, 2014, about 60,000 apps were enabled by mobile app developers to operate on Millennial Media’s platform, and Millennial Media had more than 700 million proprietary, anonymous user profiles used for delivering the most relevant ads to consumers, counting over 60 million cross screen profiles linking users across mobile devices and PCs.
Outlook:
For the first quarter of 2015, Millennial Media presently anticipates total gross billings to be in the range of $69.0 million to $72.0 million, comprised of $50.0 million to $52.0 million for its managed media business and $19.0 million to $20.0 million for its platform business. Gross billings is a new metric that Millennial Media is introducing for the first quarter of 2015 and is defined as total dollars spent across both the managed media and platform businesses. For Millennial Media’s managed media business, gross billings is the same as GAAP proceed. However, for GAAP purposes, Millennial Media’s proceed from Nexage activity in its platform business is recorded on a net, rather than gross, basis. In this portion of the platform business, the Corporation has determined it is acting as the agent and not the principal in the relationship and therefore records proceeds net of media costs. Millennial Media believes that gross billings, which is calculated before media costs, provides investors with a view of the overall dollars spent across its platform business.
Millennial Media anticipates total GAAP proceed for the first quarter of 2015 to be in the range of $55.0 million to $58.0 million, comprised of managed media GAAP proceed between $50.0 million to $52.0 million and platform GAAP proceed between $5.0 million to $6.0 million. We expect Adjusted EBITDA for the first quarter of 2015 to be in the range of a loss of $(14.0) million to $(15.0) million.
Millennial Media is the leading independent mobile marketplace, making mobile advertising simple for the world’s top brands, app developers, and mobile web publishers. Millennial Media’s unique data and technology assets enable its advertising clients to connect with their target audiences at scale.
Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE)
Formerly on February 25, Ampio Pharmaceuticals, Inc. (AMPE), declared results of the double-blind, multiple injection, vehicle controlled STRUT study (N=40) at 20 weeks.
The forty patient randomized (1:1) phase of the STRUT study was conducted to assure that multiple injections of Ampion™ were safe and effective. Each patient received three 4 mL intra-articular injections of Ampion™ or saline at baseline, 2 weeks and 4 weeks. There were no drug related serious adverse events stated during the 20 weeks of this trial; the top-line results are as follows:
- WOMAC A: The primary endpoint that is required for FDA approval, WOMAC A pain score, improved by 64% from baseline to 20 weeks. Ampion™ improved by -1.41 (0.81) contrast to saline vehicle control which improved by -0.85 (0.64), p=0.0231.
- Responder Rate: Responder rate is defined as a change of at least 1 point in the WOMAC A pain subscale. Responder rate for Ampion™ was 79% contrast to 47% of saline patients,p=0.0451.
Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical corporation, develops therapies for the treatment of prevalent inflammatory conditions in the United States.
Morgan Stanley (NYSE:MS)
Morgan Stanley (MS), declared recently that it received no objection from the Board of Governors of the Federal Reserve System to the Firm’s 2015 Capital Plan. This capital plan comprised of a share repurchase of up to $3.1 billion of ordinary stock for the five quarters starting in the second quarter of 2015 through the end of the second quarter of 2016, as well as an raise in the Firm’s quarterly ordinary stock dividend to $0.15 per share from the current $0.10 per share, starting with the dividend predictable to be declared in the second quarter of 2015.
Share repurchases under the Firm’s existing authorized program will be exercised from time to time through June 30, 2016, at prices Morgan Stanley deems appropriate subject to various factors, counting its capital position and market conditions. The share repurchases may be effected through open market purchases or privately negotiated transactions, counting through Rule 10b5-1 plans, and may be suspended at any time. Morgan Stanley’s Board of Directors intends to raise the quarterly ordinary stock dividend to $0.15 per share, with the dividend payable in the second quarter of 2015.
Morgan Stanley, a financial holding corporation, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
